# Viral Etiology Meta-Analysis for ME/CFS

**Authors:** Hwang J-H, Lee J-S, Oh H-M, and colleagues
**Journal:** Journal of Translational Medicine, 21(1):763, 2023
**DOI:** 10.1186/s12967-023-04635-0
**PMID:** 37898798

## Key Points

- **Largest meta-analysis of viral associations:** 64 studies, 4,971 ME/CFS patients, 9,221 controls
- **18 viral species analyzed:** Comprehensive coverage of suspected viral triggers
- **Five viruses with strong associations (OR >2.0):** BDV, HHV-7, parvovirus B19, enterovirus, coxsackie B
- **Borna disease virus strongest:** OR ≥3.47 (moderate association level)
- **High heterogeneity for EBV and enterovirus:** Suggests subgroup effects or methodological variability

## Methodology

**Study Design:** Systematic review and meta-analysis

**Search Strategy:**
- Databases: PubMed, Cochrane Library
- Date range: Through December 31, 2022
- Search terms: ME/CFS + viral infection + various virus names
- Inclusion criteria: Studies comparing viral prevalence in ME/CFS vs. controls

**Sample Size:**
- Total studies: 64 included
- ME/CFS patients: 4,971
- Control subjects: 9,221
- Control types: Both healthy controls and diseased controls

**Statistical Methods:**
- Odds ratio calculations with 95% confidence intervals
- Heterogeneity assessment (I² statistic)
- Comparison against healthy controls AND diseased controls separately
- Subgroup analyses where data permitted

## Results Summary

### Viruses with Strong Associations (OR >2.0)

#### 1. Borna Disease Virus (BDV)
- **Odds Ratio:** ≥3.47
- **Significance:** Strongest association found; exceeded cutoff vs. both control types
- **Classification:** "Moderate association"
- **Note:** BDV is neurotropic RNA virus, controversial in human disease

#### 2. Human Herpesvirus-7 (HHV-7)
- **Odds Ratio:** >2.0
- **Virus type:** DNA herpesvirus, related to HHV-6
- **Prevalence:** High in general population; reactivation may be key

#### 3. Parvovirus B19
- **Odds Ratio:** >2.0
- **Note:** Includes co-infections with other viruses
- **Clinical relevance:** Known to cause persistent infections

#### 4. Enterovirus
- **Odds Ratio:** >2.0
- **Heterogeneity:** >50% with diseased controls (high variability across studies)
- **Historical context:** Multiple ME/CFS epidemics coincided with polio outbreaks (see O'Neal 2021)

#### 5. Coxsackie B Virus
- **Odds Ratio:** >2.0
- **Virus type:** Enterovirus subtype
- **Known effects:** Cardiac and muscle involvement

### Viruses with Weaker/Variable Associations

#### Epstein-Barr Virus (EBV)
- **Heterogeneity:** >50% with healthy controls
- **Interpretation:** Inconsistent findings across studies; may depend on:
  - ME/CFS subgroup (post-mono vs. other onset)
  - Detection method (serology vs. PCR)
  - Timing of measurement relative to onset
- **Note:** Despite heterogeneity, EBV remains clinically important trigger (see Ruiz-Pablos 2021)

### Other Viruses Analyzed (OR <2.0 or insufficient data)
- HHV-6 (mixed results)
- Cytomegalovirus (CMV)
- Other herpesviruses
- Influenza viruses
- SARS-CoV-2 (limited data, mostly long COVID literature)

## Relevance to ME/CFS Documentation

### Strength of Evidence
This meta-analysis provides **MODERATE evidence** for viral associations, particularly for:
- BDV (strongest, OR≥3.47)
- HHV-7, parvovirus B19, enteroviruses (moderate, OR>2.0)

### Limitations and Caveats

1. **Association ≠ Causation:**
   - Viral markers elevated, but direction of causality unclear
   - Could be: (a) virus triggers ME/CFS, (b) ME/CFS allows viral reactivation, (c) shared susceptibility

2. **High heterogeneity:**
   - EBV and enterovirus findings vary widely across studies
   - Suggests subgroup effects, methodological differences, or temporal factors

3. **Methodological variability:**
   - Studies used different detection methods (serology, PCR, immunohistochemistry)
   - Different tissue sampling (blood, muscle, CNS)
   - Different diagnostic criteria for ME/CFS

4. **Publication bias possible:**
   - Studies finding positive associations more likely to be published

5. **BDV controversy:**
   - Borna disease virus in humans remains controversial
   - Possible lab contamination in some studies
   - Requires validation with rigorous methods

### Integration with Existing Literature

**Complements:**
- **Ruiz-Pablos 2021:** EBV immune evasion mechanism (despite heterogeneity, EBV clinically important)
- **O'Neal 2021:** Enterovirus theory supported by OR>2.0 finding
- **Nunes 2024:** Herpesvirus endothelial hypothesis (HHV-7 OR>2.0 provides support)
- **Syed 2025, Wang 2023:** Viral triggers → ER stress → mitochondrial dysfunction pathway

**Clarifies:**
- **Which viruses most strongly associated:** BDV>HHV-7≈parvovirus≈enterovirus>others
- **EBV heterogeneity explains:** Why some studies find strong EBV links, others don't
- **Subgroup implications:** Different viral triggers may define different ME/CFS subgroups

## Certainty Assessment

- **Study Quality:** HIGH (systematic review with meta-analysis, rigorous methods)
- **Sample Size:** LARGE (n=4,971 ME/CFS patients across 64 studies)
- **Replication:** REPLICATED (multiple studies included for each virus)
- **Effect Size:** MODERATE (OR 2.0-3.47 range, not extremely strong)
- **Consistency:** VARIABLE (high heterogeneity for EBV, enterovirus)
- **Conflicts of Interest:** None apparent

### Overall Evidence Level: MODERATE

**Strong enough to state:**
- Viral associations exist (OR>2.0 for multiple viruses)
- BDV shows strongest association (OR≥3.47)
- Multiple viral triggers implicated (not single virus)

**Not strong enough to state:**
- Viruses CAUSE ME/CFS (association, not causation proven)
- All ME/CFS patients have viral etiology (heterogeneity suggests subgroups)
- Specific mechanism by which viruses trigger chronic state

## Quotes for Citation

> "64 studies met our eligibility criteria regarding 18 species of viruses, including a total of 4971 ME/CFS patients and 9221 control subjects."

> "Two DNA viruses (human herpes virus (HHV)-7 and parvovirus B19, including their co-infection) and 3 RNA viruses (borna disease virus (BDV), enterovirus and coxsackie B virus) showed odds ratios greater than 2.0."

> "BDV exceeded the cutoff with an odds ratio of ≥ 3.47 (indicating a 'moderate association') compared to both healthy and diseased controls."

> "EBV (with healthy controls) and enterovirus (with diseased controls) showed over 50% heterogeneity, indicating variability in the study results."

## Integration Recommendations

### Primary Integration Points

1. **Chapter 2: Viral Triggers and Onset**
   - Core citation for viral etiology section
   - Table showing OR for each virus
   - Discussion of heterogeneity and subgroup implications

2. **Chapter 3: Pathophysiology**
   - Link viral triggers to downstream mechanisms (ER stress, mitochondrial dysfunction)
   - Note multiple viral pathways may converge on common mechanisms

3. **Chapter 1: Introduction/Etiology**
   - Overview of viral associations
   - Distinction between association and causation

### Environment Usage

- **`observation`:** Viral associations with OR>2.0 (replicated across studies, moderate evidence)
  - BDV OR≥3.47
  - HHV-7, parvovirus B19, enterovirus, coxsackie B OR>2.0

- **`hypothesis`:** Causation direction (trigger vs. reactivation vs. shared susceptibility)

- **`warning`:** Heterogeneity in findings; association ≠ causation

- **`open_question`:** Why such high heterogeneity for EBV and enterovirus? Which viral subgroups exist?

### Required Caveats

- **ALWAYS note:** Association, NOT proven causation
- **ALWAYS note:** Sample sizes (n=4,971 ME/CFS, n=9,221 controls, 64 studies)
- **ALWAYS note:** Heterogeneity for EBV and enterovirus (>50%)
- **BDV caution:** Controversy over BDV in human disease; strongest association but requires validation
- **Subgroup interpretation:** Findings suggest viral etiology may apply to subgroups, not all patients

### Cross-Virus Integration

Different viruses may trigger ME/CFS through different mechanisms:

1. **Herpesviruses (EBV, HHV-7):**
   - Latency and reactivation cycles
   - Endothelial infection (Nunes 2024)
   - Immune evasion (Ruiz-Pablos 2021)

2. **Enteroviruses (enterovirus, coxsackie B):**
   - CNS persistence (O'Neal 2021)
   - Mitochondrial protein downregulation (O'Neal 2021)
   - Cardiac/muscle involvement

3. **Parvovirus B19:**
   - Persistent infections
   - Bone marrow involvement

4. **BDV:**
   - Neurotropic effects
   - Controversial in humans; requires validation

## Comparison with Single-Virus Papers

**Hwang 2023 provides meta-analytic quantification for:**
- Ruiz-Pablos 2021 (EBV): Heterogeneous but supported
- O'Neal 2021 (enterovirus): OR>2.0 supports enterovirus theory
- Nunes 2024 (herpesviruses): HHV-7 OR>2.0 supports herpesvirus-endothelial hypothesis

**Adds new findings:**
- BDV strongest association (OR≥3.47) - not covered in other papers
- Parvovirus B19 association (OR>2.0) - not extensively discussed elsewhere
- Quantitative comparison across 18 viral species

## Table for Integration

**Suggested table for Chapter 2:**

| Virus | Odds Ratio | Virus Type | Evidence Quality |
|-------|-----------|-----------|-----------------|
| Borna disease virus | ≥3.47 | RNA | Moderate (requires validation) |
| HHV-7 | >2.0 | DNA herpesvirus | Moderate |
| Parvovirus B19 | >2.0 | DNA parvovirus | Moderate |
| Enterovirus | >2.0 | RNA enterovirus | Moderate (high heterogeneity) |
| Coxsackie B | >2.0 | RNA enterovirus | Moderate |
| EBV | Variable | DNA herpesvirus | Moderate (high heterogeneity) |

*Source: Hwang et al. 2023, n=4,971 ME/CFS patients, 9,221 controls, 64 studies*
